Abstract
Fulvestrant (Faslodex(A (R))), a selective estrogen receptor (ER) degrader, is now indicated for the treatment of ER+ or hormone-receptor positive (HR......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
